Literature DB >> 2589653

Disposition kinetics of ropivacaine in humans.

A Lee1, D Fagan, M Lamont, G T Tucker, M Halldin, D B Scott.   

Abstract

The pharmacokinetic characteristics of a new local anesthetic drug, ropivacaine, were determined after intravenous infusion of 50 mg of the hydrochloride salt into six healthy male volunteers. Results showed that the disposition of ropivacaine can be described by a biexponential function. Its blood clearance (0.72 +/- 0.16 L/min) is intermediate between that of mepivacaine and bupivacaine. Plasma binding averaged 94% +/- 1% and the volume of distribution at steady state based on blood drug concentration was 59 +/- 7 L. The terminal elimination half-life was 111 +/- 62 min.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589653

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  18 in total

1.  Flip-flop kinetics of ropivacaine during continuous epidural infusion influences its accumulation rate.

Authors:  Maria Cusato; Massimo Allegri; Tekla Niebel; Pablo Ingelmo; Monica Broglia; Antonio Braschi; Mario Regazzi
Journal:  Eur J Clin Pharmacol       Date:  2010-11-16       Impact factor: 2.953

Review 2.  Long-acting local anesthetics in dentistry.

Authors:  A L Sisk
Journal:  Anesth Prog       Date:  1992

3.  Population Pharmacokinetic-Pharmacodynamic Modeling of Ropivacaine in Spinal Anesthesia.

Authors:  Zoubir Djerada; Catherine Feliu; Yoann Cazaubon; Faouzi Smati; Philippe Gomis; Dominique Guerrot; Beny Charbit; Olivier Fernandes; Jean-Marc Malinovsky
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

4.  Pharmacokinetics and efficacy of 40 ml ropivacaine 7.5 mg/ml (300 mg), for axillary brachial plexus block--an open pilot study.

Authors:  W Wank; J Büttner; K Rissler Maier; B M Emanuelson; D Selander
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jan-Mar       Impact factor: 2.441

5.  Plasma concentrations of ropivacaine given with or without epinephrine for brachial plexus block.

Authors:  R Hickey; J Blanchard; J Hoffman; J Sjovall; S Ramamurthy
Journal:  Can J Anaesth       Date:  1990-11       Impact factor: 5.063

Review 6.  Preliminary risk-benefit analysis of ropivacaine in labour and following surgery.

Authors:  I Cederholm
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

Review 7.  Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions.

Authors:  J M Thomas; S A Schug
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

8.  Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability.

Authors:  Eva Arlander; Jan Sjövall; Jörgen Sörstad; Carina Norsten-Höög; Lars L Gustafsson
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

9.  No Difference in Early Analgesia Between Liposomal Bupivacaine Injection and Intrathecal Morphine After TKA.

Authors:  John W Barrington; Roger H Emerson; Scott T Lovald; Adolph V Lombardi; Keith R Berend
Journal:  Clin Orthop Relat Res       Date:  2017-01       Impact factor: 4.176

10.  Epinephrine Affects Pharmacokinetics of Ropivacaine Infiltrated Into Palate.

Authors:  Mikiko Yamashiro; Shuichi Hashimoto; Asako Yasuda; Katsuhisa Sunada
Journal:  Anesth Prog       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.